Sharon Marie Jenkins, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2028 Stony Hill Rd, Hinckley, OH 44233 Phone: 330-273-5062 |
Nancy Lightner, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1675 Hinckley Hills Rd, Hinckley, OH 44233 Phone: 330-278-3148 |
Mrs. Letisha Ann Prince, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2498 Kellogg Road, Hinckley, OH 44233 Phone: 440-315-4381 |
News Archive
Patients who've been hurt in car or bike crashes, been shot or stabbed, or suffered other injuries are more likely to live if they arrive at the hospital on the weekend than during the week, according to new University of Pennsylvania School of Medicine research published in the March 21 issue of Archives of Surgery.
Cancer ranks as a leading cause of death in every country in the world, and, for the first time, female breast cancer is the most commonly diagnosed cancer, overtaking lung cancer, according to a collaborative report, Global Cancer Statistics 2020, from the American Cancer Society and the International Agency for Research on Cancer.
California Healthcare Institute today announced the release of a new white paper titled "Upcoming Changes to the 510(k) Process: New Approval Pathways and the Impact on Medical Device Development and Innovation." CHI is a non-profit public policy research and advocacy organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.
› Verified 8 days ago